250 related articles for article (PubMed ID: 27417251)
21. Pulmonary vascular disease in pulmonary hypertension due to left heart disease: pathophysiologic implications.
Omote K; Sorimachi H; Obokata M; Reddy YNV; Verbrugge FH; Omar M; DuBrock HM; Redfield MM; Borlaug BA
Eur Heart J; 2022 Sep; 43(36):3417-3431. PubMed ID: 35796488
[TBL] [Abstract][Full Text] [Related]
22. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
Liden H; Haraldsson A; Ricksten SE; Kjellman U; Wiklund L
Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
[TBL] [Abstract][Full Text] [Related]
23. Combined post- and pre-capillary pulmonary hypertension in heart failure with preserved ejection fraction.
Dixon DD; Trivedi A; Shah SJ
Heart Fail Rev; 2016 May; 21(3):285-97. PubMed ID: 26714826
[TBL] [Abstract][Full Text] [Related]
24. Pulmonary hypertension due to left heart disease.
Vachiéry JL; Tedford RJ; Rosenkranz S; Palazzini M; Lang I; Guazzi M; Coghlan G; Chazova I; De Marco T
Eur Respir J; 2019 Jan; 53(1):. PubMed ID: 30545974
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and Safety of the Use of Pulmonary Arterial Hypertension Pharmacotherapy in Patients with Pulmonary Hypertension Secondary to Left Heart Disease: A Systematic Review.
Kido K; Coons JC
Pharmacotherapy; 2019 Sep; 39(9):929-945. PubMed ID: 31349390
[TBL] [Abstract][Full Text] [Related]
26. Pulmonary Hypertension in Left Heart Diseases: Pathophysiology, Hemodynamic Assessment and Therapeutic Management.
Ltaief Z; Yerly P; Liaudet L
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373119
[TBL] [Abstract][Full Text] [Related]
27. Pulmonary hypertension associated with left heart disease.
Wissmüller M; Dohr J; Adler J; Ochs L; Tichelbäcker T; Hohmann C; Baldus S; Rosenkranz S
Herz; 2023 Aug; 48(4):266-273. PubMed ID: 37289211
[TBL] [Abstract][Full Text] [Related]
28. Update in approaches to pulmonary hypertension because of left heart disease.
Kennedy JLW; Mihalek AD
Curr Opin Pulm Med; 2022 Sep; 28(5):337-342. PubMed ID: 35838362
[TBL] [Abstract][Full Text] [Related]
29. Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients.
Mikus E; Stepanenko A; Krabatsch T; Loforte A; Dandel M; Lehmkuhl HB; Hetzer R; Potapov EV
Eur J Cardiothorac Surg; 2011 Oct; 40(4):971-7. PubMed ID: 21354812
[TBL] [Abstract][Full Text] [Related]
30. Combined pre- and post-capillary pulmonary hypertension: The clinical implications for patients with heart failure.
Ibe T; Wada H; Sakakura K; Ugata Y; Maki H; Yamamoto K; Seguchi M; Taniguchi Y; Jinnouchi H; Momomura SI; Fujita H
PLoS One; 2021; 16(3):e0247987. PubMed ID: 33651852
[TBL] [Abstract][Full Text] [Related]
31. A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats.
Sang P; Kucherenko MM; Yao J; Li Q; Simmons S; Kuebler WM; Knosalla C
J Vis Exp; 2022 Mar; (181):. PubMed ID: 35311828
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of reactive post-capillary pulmonary hypertension in patients with left heart disease.
Tatebe S; Fukumoto Y; Sugimura K; Miyamichi-Yamamoto S; Aoki T; Miura Y; Nochioka K; Satoh K; Shimokawa H
Circ J; 2012; 76(5):1235-44. PubMed ID: 22313804
[TBL] [Abstract][Full Text] [Related]
33. Management of Pulmonary Hypertension: Associated with Left Heart Disease.
Franco V
Heart Fail Clin; 2018 Oct; 14(4):545-551. PubMed ID: 30266363
[TBL] [Abstract][Full Text] [Related]
34. Clinical-imaging-pathological correlation in pulmonary hypertension associated with left heart disease.
van de Veerdonk MC; Roosma L; Trip P; Gopalan D; Vonk Noordegraaf A; Dorfmüller P; Nossent EJ
Eur Respir Rev; 2024 Jan; 33(171):. PubMed ID: 38417969
[TBL] [Abstract][Full Text] [Related]
35. Pulmonary Hypertension in the Era of Mechanical Circulatory Support.
Krishnamurthy Y; Cooper LB; Parikh KS; Felker GM; Milano CA; Rogers JG; Hernandez AF; Patel CB
ASAIO J; 2016; 62(5):505-12. PubMed ID: 27442856
[TBL] [Abstract][Full Text] [Related]
36. Updates in the Pharmacotherapy of Pulmonary Hypertension in Patients with Heart Failure with Preserved Ejection Fraction.
Segovia F; Garcia H; Alkhateeb H; Mukherjee D; Nickel N
Cardiovasc Hematol Disord Drug Targets; 2023; 23(4):215-225. PubMed ID: 37921162
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary Hypertension in Heart Failure. Epidemiology, Right Ventricular Function, and Survival.
Gerges M; Gerges C; Pistritto AM; Lang MB; Trip P; Jakowitsch J; Binder T; Lang IM
Am J Respir Crit Care Med; 2015 Nov; 192(10):1234-46. PubMed ID: 26181215
[TBL] [Abstract][Full Text] [Related]
38. Persistent abnormalities in pulmonary arterial compliance after heart transplantation in patients with combined post-capillary and pre-capillary pulmonary hypertension.
Ghio S; Crimi G; Pica S; Temporelli PL; Boffini M; Rinaldi M; Raineri C; Scelsi L; Pistono M; Totaro R; Guida S; Oltrona Visconti L
PLoS One; 2017; 12(11):e0188383. PubMed ID: 29176890
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary Hypertension Due to Left Heart Disease-A Practical Approach to Diagnosis and Management.
Lee F; Mielniczuk LM
Can J Cardiol; 2021 Apr; 37(4):572-584. PubMed ID: 33217522
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary Vascular Disease: Hemodynamic Assessment and Treatment Selection-Focus on Group II Pulmonary Hypertension.
Ramu B; Houston BA; Tedford RJ
Curr Heart Fail Rep; 2018 Apr; 15(2):81-93. PubMed ID: 29417467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
